therapies
-
Biologics
Orthofix Announces New President for Bone Growth Therapies Business
LEWISVILLE, Texas, February 29, 2024 –(BUSINESS WIRE)– Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced…
Read More » -
Biologics
Xlife Sciences and curasan form joint venture company to research biosurgical treatment therapies
Kleinostheim, Germany, 21 March 2022, OrthoSpineNews – Xlife Sciences AG (SIX: XLS) and curasan AG, a leading global provider of…
Read More » -
Biologics
BioRestorative Therapies Announces Completion of Human Safety and Feasibility Study on the Use of Hypoxic Cultured Stem Cells to Treat Chronic Lower Back Pain
MELVILLE, N.Y., June 28, 2016 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BRT” or the “Company”) (OTCBB:BRTX), a life sciences company…
Read More »